Close

IMMU Financial Facts

Sales and marketing: 215.86K
Foreign currency transaction gain: 2.46K
See Full Income Statement

Total Assets: 40.61M
Other long-term assets: 30K
See Full Balance Sheet

Immunomedics (IMMU) Earnings

  |   Expand Research on IMMU
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -44.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +2.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/20 Q220 N/A-$0.34 N/A N/A$14.53M N/A N/A N/A
5/6/20 Q120 -$0.44-$0.45 +$0.01N/A$2.36M N/A Details
2/27/20 Q419 -$0.50-$0.46 -$0.04$295K$530K N/A Details
10/30/19 Q319 -$0.49-$0.40 -$0.09N/A$400K N/A Details
2/25/19 Q219 -$0.84-$0.34 -$0.50N/A$50K N/A Details
11/7/18 Q119 -$0.34N/A N/A N/A$1.86M N/A Details
8/23/18 Q418 -$0.68-$0.22 -$0.46$400K$4.27M N/A Details
5/9/18 Q318 -$0.21-$0.15 -$0.06$500M$1.3M = Details